NBC Securities’s Ligand Pharmaceuticals LGND Stock Holding History

NBC Securities’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$88.5K	Buy	+280	New	+$66K	0.01%	1116

Other funds holding LGND

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Pembroke Management Montreal, Quebec, Canada $637M AUM 40.98% 1-Year Est. Return

Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return

Isthmus Partners Madison, Wisconsin $1.03B AUM 22.86% 1-Year Est. Return

Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return

Moody National Bank Trust Division Galveston, Texas $1.21B AUM 38.93% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

Linden Thomas Advisory Services Charlotte, North Carolina $1.24B AUM 47.37% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

NBC Securities's LGND Position: Q2 2026 in Review

NBC Securities opened a new position in Ligand Pharmaceuticals (LGND) in Q2 2026: 280 shares worth $88.5K. The stake represents 0.01% of the portfolio and ranks #1116 among its holdings.

59 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

NBC Securities held 280 shares of Ligand Pharmaceuticals worth $88.5K as of Q2 2026.
Ligand Pharmaceuticals was a new NBC Securities position in Q2 2026.
Ligand Pharmaceuticals made up 0.01% of NBC Securities's portfolio in Q2 2026, its #1116 holding.
59 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.